Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 3 | Vintage Vibes

How did monkeypox emerge in the US when the first diagnosed patient hadn’t left the country?

When a local man arrived in a Boston emergency department on May 12 with an unusual mix of symptoms, doctors were scratching their heads for days.

ABC News · Jun 8, 2022

President Biden says ‘everybody’ should be concerned about monkeypox after CDC urges calm

President Biden says ‘everybody’ should be concerned about monkeypox after CDC urges calm

President said officials are determining ‘what vaccine if any might be available for it’ after US already ordered millions of doses of smallpox vaccine that is effective against monkeypox

The Independent UK · May 22, 2022

New York City patient tests positive for virus related to monkeypox with officials urging people to wear masks

New York City patient tests positive for virus related to monkeypox with officials urging people to wear masks

Patient is presumed to be positive ahead of CDC confirmation, likely making them the second confirmed case on US soil this year

The Independent UK · May 21, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

NeuroSense Shares Surge Over 400% As FDA Clears Initiating Pharmacokinetic Study Of PrimeC

NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects. PrimeC is a novel extended-release oral formulation composed of a fixed-dose combination of ciprofloxacin and celecoxib. PrimeC targets several key mechanisms of amyotrophic lateral sclerosis (ALS) that contribute to motor neuron degeneration,…

Benzinga · Mar 21, 2022

Tonix Pharma Collaborates With Massachusetts General Hospital For TNX-1900 In Binge Eating Disorder

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced an agreement with Massachusetts General Hospital to evaluate TNX-1900 (intranasal potentiated oxytocin) in a Phase 2 trial as a potential treatment for binge eating disorder. The Phase 2 clinical trial is expected to start in 2H of 2022. TNX-1900 is also in development for the treatment…

Benzinga · Mar 7, 2022

1 2 3

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

European Medicines Agency

Massachusetts General Hospital

Tonix Pharmaceuticals Holding Corp

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play